- Home
- RPTX vs PETS Comparison
RPTX vs PETS Comparison
Compare RPTX & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- PETS
- Stock Information
- Founded
- RPTX 2016
- PETS 1996
- Country
- RPTX Canada
- PETS United States
- Employees
- RPTX N/A
- PETS N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- RPTX Health Care
- PETS Consumer Staples
- Exchange
- RPTX Nasdaq
- PETS Nasdaq
- Market Cap
- RPTX 63.9M
- PETS 70.4M
- IPO Year
- RPTX 2020
- PETS N/A
- Fundamental
- Price
- RPTX $1.56
- PETS $3.77
- Analyst Decision
- RPTX Strong Buy
- PETS Sell
- Analyst Count
- RPTX 3
- PETS 2
- Target Price
- RPTX $4.50
- PETS $3.35
- AVG Volume (30 Days)
- RPTX 717.8K
- PETS 163.8K
- Earning Date
- RPTX 08-05-2025
- PETS 08-05-2025
- Dividend Yield
- RPTX N/A
- PETS N/A
- EPS Growth
- RPTX N/A
- PETS N/A
- EPS
- RPTX N/A
- PETS 0.02
- Revenue
- RPTX $1,073,000.00
- PETS $247,010,000.00
- Revenue This Year
- RPTX N/A
- PETS N/A
- Revenue Next Year
- RPTX N/A
- PETS N/A
- P/E Ratio
- RPTX N/A
- PETS $220.93
- Revenue Growth
- RPTX N/A
- PETS N/A
- 52 Week Low
- RPTX $0.89
- PETS $2.90
- 52 Week High
- RPTX $4.22
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- RPTX 58.19
- PETS 59.64
- Support Level
- RPTX $1.37
- PETS $3.00
- Resistance Level
- RPTX $1.68
- PETS $3.60
- Average True Range (ATR)
- RPTX 0.08
- PETS 0.19
- MACD
- RPTX 0.00
- PETS 0.08
- Stochastic Oscillator
- RPTX 61.29
- PETS 70.00
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.